Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 4 minute read Pharma Industry News Charlotte’s Web and DeFloria advance Autism treatment with FDA Phase 2 approval Charlotte’s Web Holdings, Inc., a recognized leader in hemp-derived wellness products, has announced a major development in the… byPallavi MadhirajuFebruary 25, 2025